EndoNaut two-dimensional fusion imaging with a mobile C-arm for endovascular treatment of occlusive peripheral arterial disease.

Caroline Caradu¹, Katherine Stenson², Hassan Houmaïda³, Julie Le Ny⁴, Florent Lalys⁴, Eric Ducasse⁵, Benoit Gheysens³

¹Department of Vascular Surgery, Bordeaux University Hospital, Bordeaux, France. Electronic address: caroline.caradu@chu-bordeaux.fr.

²Department of Vascular Surgery, Imperial College London, London, UK.

³Department of Vascular Surgery, Libourne Hospital, Libourne, France.

⁴Department of Image-Guided Surgical Navigation in Endovascular Procedures, Therenva SAS, Rennes, France.

⁵Department of Vascular Surgery, Bordeaux University Hospital, Bordeaux, France.

PubMed DOI

Abstract

BACKGROUND: Endovascular treatment has become the first-line strategy for peripheral arterial disease (PAD). Given the number of procedures required, any technology associated with a reduction in radiation exposure and contrast volume is highly relevant. In the present study, we evaluated whether two-dimensional (2D) fusion imaging could reduce the radiation exposure and contrast volume during end…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.